Plant-derived secondary metabolites tetrahydropalmatine and rutaecarpine alleviate paclitaxel-induced neuropathic pain via TRPV1 and TRPM8 modulation.
Park, Keun-Tae, et al. · Metabolites. 2026;16(1). IF 4.5 (2025). doi.org/10.3390/metabo16010046
Team WoojinCollege of Korean MedicineKyung Hee University
Publications
Team Woojin lists 54 papers from 2013 through 2026. The work covers neuropathic pain, oligodendrocytes and myelin, chemotherapy-induced neuropathy, anorexia, and plant-derived compounds. Where a 2025 Journal Impact Factor is available from the 2026 Journal Citation Reports, it is shown beside the citation. Citation years follow the references. Granted patents are not listed yet.
No papers match that filter.
Park, Keun-Tae, et al. · Metabolites. 2026;16(1). IF 4.5 (2025). doi.org/10.3390/metabo16010046
Jeon, Yong Jae, et al. · Phytomedicine. 2026;153:157935. IF 11.3 (2025). doi.org/10.1016/j.phymed.2026.157935
Park, Keun-Tae, et al. · Journal of Ginseng Research. 2026;50(4):101047. IF 7.5 (2025). doi.org/10.1016/j.jgr.2026.101047
Jo, Heejoon, et al. · Integrative Medicine Research. 2026;15(4):101350. IF 4.9 (2025). doi.org/10.1016/j.imr.2026.101350
Kim, Woojin, and María Cecilia Angulo · Journal of Neurochemistry. 2025;169(1):e16206. IF 4.6 (2025). doi.org/10.1111/jnc.16206
Park, Keun-Tae, et al. · Pharmaceuticals. 2024;17(9):1179. IF 5.7 (2025). doi.org/10.3390/ph17091179
Park, K. T., et al. · Metabolites. 2024;14(12):719. IF 4.5 (2025). doi.org/10.3390/metabo14120719
Park, Keun-Tae, et al. · Frontiers in Pharmacology. 2023;13:1055264. IF 5.4 (2025). doi.org/10.3389/fphar.2022.1055264
Park, Keun-Tae, et al. · Biomedicines. 2023;11(2):432. IF 4.5 (2025). doi.org/10.3390/biomedicines11020432
Gang, Juan, et al. · Pharmaceuticals. 2023;16(10):1465. IF 5.7 (2025). doi.org/10.3390/ph16101465
Park, Keun-Tae, Seong-Gyu Ko, and Woojin Kim · Plants. 2023;12(22):3819. IF 4.7 (2025). doi.org/10.3390/plants12223819
Park, Keun Tae, et al. · Life. 2023;13(12):2289. IF 3.9 (2025). doi.org/10.3390/life13122289
Jung, W., et al. · Heliyon. 2023;9(10):e20889. IF 4.1 (2025). doi.org/10.1016/j.heliyon.2023.e20889
Kim, Hyeonah, et al. · Frontiers in Pharmacology. 2023;14:1267254. IF 5.4 (2025). doi.org/10.3389/fphar.2023.1267254
Li, X., et al. · Complementary Therapies in Medicine. 2023;78:102992. IF 4.0 (2025). doi.org/10.1016/j.ctim.2023.102992
Lee, Ji Hwan, et al. · Current Issues in Molecular Biology. 2022;44(2):718–730. IF 4.1 (2025). doi.org/10.3390/cimb44020050
Min, Daeun, et al. · Pharmaceuticals. 2022;15(2):208. IF 5.7 (2025). doi.org/10.3390/ph15020208
Kim, Suyong, et al. · Pharmaceuticals. 2022;15(6):726. IF 5.7 (2025). doi.org/10.3390/ph15060726
Kim, Suyong, et al. · Plants. 2022;11(17):2296. IF 4.7 (2025). doi.org/10.3390/plants11172296
Shin, Yuchan, Bonglee Kim, and Woojin Kim · Plants. 2022;11(23):3395. IF 4.7 (2025). doi.org/10.3390/plants11233395
Yang, Eunhee, et al. · Frontiers in Neuroscience. 2022;16:867831. IF 4.0 (2025). doi.org/10.3389/fnins.2022.867831
Lee, Ji Hwan, et al. · Molecules. 2021;26(3):548. IF 5.1 (2025). doi.org/10.3390/molecules26030548
Kim, W. · Toxins. 2021;13(3):191. IF 4.0 (2025). doi.org/10.3390/toxins13030191
Lee, J. H., and W. Kim · Biomedicines. 2021;9(8):970. IF 4.5 (2025). doi.org/10.3390/biomedicines9080970
Cho, Eunwoo, and Woojin Kim · International Journal of Molecular Sciences. 2021;22(16):8575. IF 5.6 (2025). doi.org/10.3390/ijms22168575
Lee, Ji Hwan, et al. · International Journal of Molecular Sciences. 2021;22(16):8811. IF 5.6 (2025). doi.org/10.3390/ijms22168811
Hong, Minwoo, et al. · International Journal of Molecular Sciences. 2021;22(6):3188. IF 5.6 (2025). doi.org/10.3390/ijms22063188
Kim, Sejin, et al. · Processes. 2021;9(8):1344. IF 3.4 (2025). doi.org/10.3390/pr9081344
Lee, Ji Hwan, et al. · Toxins. 2020;12(12):737. IF 4.0 (2025). doi.org/10.3390/toxins12120737
Kim, Woojin · Processes. 2020;8(6):680. IF 3.4 (2025). doi.org/10.3390/pr8060680
Lee, J. H., and W. Kim · Biomedicines. 2020;8(9):324. IF 4.5 (2025). doi.org/10.3390/biomedicines8090324
Choi, S., et al. · Toxins. 2019;11(7):396. IF 4.0 (2025). doi.org/10.3390/toxins11070396
Chae, Hyeon Kyeong, Woojin Kim, and Sun Kwang Kim · Nutrients. 2019;11(2):432. IF 5.8 (2025). doi.org/10.3390/nu11020432
Li, Daxian, et al. · International Journal of Molecular Sciences. 2019;20(7):1652. IF 5.6 (2025). doi.org/10.3390/ijms20071652
Lee, Gihyun, et al. · Evidence-Based Complementary and Alternative Medicine. 2018:6960125. doi.org/10.1155/2018/6960125
Kim, Woojin, Sun Kwang Kim, and Junichi Nabekura · Journal of Neurochemistry. 2017;141(4):499–506. IF 4.6 (2025). doi.org/10.1111/jnc.14012
Lee, Gihyun, and Woojin Kim · Evidence-Based Complementary and Alternative Medicine. 2017:9785345. doi.org/10.1155/2017/9785345
Kim, Min Joon, et al. · The Korean Journal of Physiology & Pharmacology. 2017;21(6):657–666. IF 2.5 (2025). doi.org/10.4196/kjpp.2017.21.6.657
Kim, Woojin, et al. · International Journal of Molecular Sciences. 2017;18(12):2626. IF 5.6 (2025). doi.org/10.3390/ijms18122626
Choi, Jiho, et al. · Toxins. 2017;9(11):351. IF 4.0 (2025). doi.org/10.3390/toxins9110351
Jung, Yongjae, et al. · BMC Complementary and Alternative Medicine. 2017;17(1):48. IF 4.4 (2025). doi.org/10.1186/s12906-017-1556-z
Choi, Seunghwan, et al. · The Journal of Physiological Sciences. 2017;67(3):431–438. doi.org/10.1007/s12576-016-0505-9
Kim, Woojin, et al. · Toxins. 2016;8(2):33. IF 4.0 (2025). doi.org/10.3390/toxins8020033
Kim, Woojin, and Sun Kwang Kim · The Korean Journal of Physiology & Pharmacology. 2016;20(1):1–8. IF 2.5 (2025). doi.org/10.4196/kjpp.2016.20.1.1
Hong, Mi Kyoung, et al. · Oriental Pharmacy and Experimental Medicine. 2016;16(4):251–257. doi.org/10.1007/s13596-016-0233-y
Li, Dongxing, et al. · Toxins. 2016;8(1):27. IF 4.0 (2025). doi.org/10.3390/toxins8010027
Lee, Ji Hwan, et al. · The Korean Journal of Physiology & Pharmacology. 2016;20(4):407–414. IF 2.5 (2025). doi.org/10.4196/kjpp.2016.20.4.407
Jung, Kyung-Hwa, et al. · Toxins. 2016;8(10):269. IF 4.0 (2025). doi.org/10.3390/toxins8100269
Kim, Changmin, et al. · Molecules. 2016;21(9):1253. IF 5.1 (2025). doi.org/10.3390/molecules21091253
Kim, Woojin, et al. · Integrative Cancer Therapies. 2015;14(3):212–220. IF 3.1 (2025). doi.org/10.1177/1534735415572881
Lee, Jung-Woo, et al. · Complementary Therapies in Medicine. 2015;23(2):265–274. IF 4.0 (2025). doi.org/10.1016/j.ctim.2015.02.003
Kim, Woojin, et al. · Complementary Therapies in Medicine. 2015;23(4):626–632. IF 4.0 (2025). doi.org/10.1016/j.ctim.2015.03.011
Li, Dongxing, et al. · Toxins. 2015;7(7):2422–2434. IF 4.0 (2025). doi.org/10.3390/toxins7072422
Kim, Woojin, Sun Kwang Kim, and Byung-Il Min · Evidence-Based Complementary and Alternative Medicine. 2013:436913. doi.org/10.1155/2013/436913